# Two Rebeccamycin Analogue Regimens in Treating Patients With Advanced or Recurrent Non-small Cell Lung Cancer

> **NCT00006017** · PHASE2 · COMPLETED · sponsor: **Case Comprehensive Cancer Center** · enrollment: 42 (actual)

## Conditions studied

- Lung Cancer

## Interventions

- **DRUG:** becatecarin

## Key facts

- **NCT ID:** NCT00006017
- **Lead sponsor:** Case Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-05
- **Primary completion:** 2003-07
- **Final completion:** 2005-01
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2010-06-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00006017

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00006017, "Two Rebeccamycin Analogue Regimens in Treating Patients With Advanced or Recurrent Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00006017. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*